marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Fennec Pharmaceuticals Financial Ratios 2011-2024 | FENC
Annual Financial Ratios Fennec Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-18.4 | -8.3 | -8.4 | -9.4 | -10.0 | -12.5 | -19.1 | -9.2 | -33.8 | -9.9 | - | - | - |
P/S |
13.9 | 128.6 | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.6 | -0.9 | -0.7 | -0.8 | -0.6 | -0.5 | -0.5 | -0.2 | -0.1 | -0.2 | 0.2 | -0.2 | 0.2 |
EV (Enterprise Value) |
321 M | 203 M | 131 M | 143 M | 116 M | 103 M | 108 M | 22.1 M | 21.8 M | 21 M | 1.54 M | 5.02 M | 174 K |
EBITDA per Share |
-0.48 | -0.86 | -0.66 | -0.738 | -0.652 | -0.556 | -0.454 | -0.232 | -0.288 | -0.362 | - | - | - |
EV/EBITDA |
0.8 | -8.0 | -8.7 | -9.6 | -15.6 | -7.3 | -6.9 | -5.4 | - | - | - | ||
PEG |
-15.48 | -0.57 | -0.3 | 0.49 | 0.43 | 1.18 | 0.17 | 11.85 | 37.06 | 9.87 | - | - | - |
P/B |
-25.4 | -76.8 | 9.2 | 5.9 | 10.7 | 5.8 | 5.0 | 7.2 | 40.7 | 35.1 | - | - | - |
P/CF |
-17.2 | -10.9 | -10.2 | -10.9 | -14.1 | -15.8 | -37.0 | -12.0 | -12.0 | -12.7 | - | - | - |
ROE % |
138.06 | 923.08 | -109.98 | -62.29 | -107.58 | -46.39 | -26.33 | -78.12 | -120.26 | -354.98 | - | - | - |
ROA % |
-59.73 | -88.03 | -77.39 | -57.64 | -90.31 | -43.08 | -24.81 | -70.22 | -64.67 | -91.74 | - | - | - |
ROCE % |
-66.13 | -101.16 | -82.96 | -61.52 | -109.55 | -48.84 | -25.98 | -78.12 | -120.26 | -354.98 | - | - | - |
Current Ratio |
0.7 | 0.9 | 3.4 | 12.9 | 6.1 | 14.0 | 17.3 | 9.9 | 2.2 | 1.3 | - | - | - |
DSO |
89.0 | 183.7 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
894.1 | 6720.7 | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
89.0 | 183.7 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-805.1 | -6537.0 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Fennec Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.21 | -0.2 | 0.41 | - | -0.07 | -0.21 | -0.23 | - | -0.31 | -0.19 | -0.14 | - | -0.16 | -0.15 | -0.18 | - | -0.24 | -0.21 | -0.19 | - | -0.09 | -0.24 | 0.14 | - | -0.14 | -0.14 | -0.09 | - | -0.15 | -0.11 | -0.06 | - | -0.04 | -0.06 | -0.04 | - | -0.01 | -0.02 | 0.02 | - | 0.04 | -0.08 | -0.33 | - | -0.21 | 0.26 | -0.16 | - | -0.03 | -0.02 | 0.11 | - | -0.17 | -0.01 | 0.23 |
EBITDA per Share |
- | - | - | - | - | - | - | - | -0.3 | -0.19 | -0.14 | - | -0.16 | -0.15 | -0.19 | - | -0.23 | -0.21 | -0.19 | - | -0.09 | -0.24 | -0.13 | - | -0.15 | -0.14 | -0.1 | - | -0.14 | -0.1 | -0.06 | - | -0.04 | -0.06 | -0.04 | - | -0.03 | -0.05 | -0.04 | - | -0.06 | -0.09 | -0.05 | - | -0.01 | -0.04 | -0.02 | - | -0.03 | -49.7 | -24.5 | - | -0.05 | -0.02 | -0.05 |
ROE % |
963.76 | 870.58 | 517.34 | 156.16 | -132.53 | -438.94 | -554.29 | -377.58 | -399.59 | -132.92 | -91.49 | -58.95 | -80.28 | -79.60 | -78.31 | -83.21 | -98.45 | -92.35 | -115.52 | -77.18 | -90.08 | -87.74 | -60.05 | -32.39 | -41.18 | -37.08 | -30.91 | -17.77 | -49.79 | -55.06 | -69.37 | -80.42 | -146.94 | -155.33 | -233.59 | -318.07 | -574.50 | -907.03 | -1163.47 | -1064.93 | -1191.73 | -963.56 | -735.39 | -380.41 | -276.26 | -45.30 | 185.66 | 312.47 | -3591.70 | -7600.02 | -11608.34 | -11712.50 | -3904.17 | -3904.17 | -3904.17 |
ROA % |
-9.78 | -9.86 | -29.08 | -65.56 | -92.15 | -108.93 | -113.50 | -78.47 | -94.56 | -84.06 | -65.71 | -47.33 | -67.06 | -70.71 | -71.90 | -72.06 | -84.85 | -77.90 | -95.92 | -64.79 | -76.77 | -75.96 | -53.79 | -30.08 | -53.87 | -65.68 | -60.03 | -32.25 | -61.03 | -49.88 | -62.48 | -72.28 | -96.50 | -95.93 | -130.70 | -171.05 | -209.79 | -289.46 | -328.20 | -275.21 | -169.90 | 27.14 | 224.19 | 315.92 | 97.62 | -226.00 | -549.62 | -654.93 | -567.37 | -261.51 | 44.35 | 262.66 | 87.55 | 87.55 | 87.55 |
ROCE % |
-2.77 | 0.60 | -20.10 | -66.13 | -94.87 | -116.87 | -127.05 | -89.55 | -106.94 | -95.59 | -69.99 | -51.51 | -71.66 | -74.43 | -76.72 | -82.15 | -97.84 | -93.37 | -117.23 | -78.79 | -92.15 | -89.82 | -61.80 | -34.27 | -42.44 | -37.25 | -30.27 | -16.58 | -32.38 | -40.01 | -54.28 | -48.32 | -110.00 | -155.88 | -236.26 | -244.34 | -345.32 | -384.62 | -436.15 | -340.29 | -336.79 | -232.30 | -16.88 | 104.12 | 116.83 | 126.04 | 87.54 | 50.35 | 837.02 | 1610.98 | 2062.43 | 2114.17 | 786.67 | 476.67 | 850.83 |
Current Ratio |
0.9 | 1.0 | 1.1 | 0.7 | 0.6 | 0.7 | 0.8 | 0.9 | 1.1 | 2.2 | 2.9 | 3.4 | 3.7 | 4.8 | - | 13.4 | 13.4 | 13.4 | - | 6.2 | - | - | - | 14.0 | 11.1 | 27.1 | 19.6 | 17.3 | 6.0 | 17.3 | 17.3 | 9.9 | 9.9 | 9.9 | 9.9 | 2.2 | 2.2 | 2.2 | 2.2 | 1.4 | 1.4 | 1.4 | 1.4 | 0.6 | 0.6 | 0.6 | 0.6 | 0.3 | 0.3 | 0.3 | 0.3 | 1.0 | 1.0 | 1.0 | 1.0 |
DSO |
165.0 | 141.9 | 34.3 | - | 48.8 | 56.6 | 87.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 819.6 | 1834.9 | 2563.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
165.0 | 141.9 | 34.3 | - | 48.8 | 56.6 | 87.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
165.0 | 141.9 | 34.3 | - | -770.8 | -1778.2 | -2475.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency